Life sciences news
-
argenx and Zai Lab announce approval of VYVGART® (efgartigimod alfa injection) for generalized myasthenia gravis in China
Friday June 30th 2023
Read more
-
Flen Health receives 1.7 million grant from VLAIO for groundbreaking research on recombinant engineering of wound-healing enzymes
Monday June 26th 2023
Read more
-
argenx announces U.S. Food and Drug Administration approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in generalized myasthenia gravis
Wednesday June 21st 2023
Read more
-
argenx initiates second cohort of Phase 2 ARDA study of empasiprubart in multifocal motor neuropathy
Tuesday June 20th 2023
Read more
-
Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards
Friday June 16th 2023
Read more
-
With the platform Startup.Flanders, Flanders claims its place among international start-up ecosystems
Friday June 16th 2023
Read more
-
Confo Therapeutics enters into research collaboration for GPCR-targeting antibody discovery with AbCellera
Friday June 16th 2023
Read more
-
Biocartis announces planned operational reorganization and cost reduction program
Friday June 16th 2023
Read more
-
Your news here?
-
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
Friday June 16th 2023
Read more
-
Mithra announces new positive preclinical data from CSF-1R inhibitor program
Thursday June 15th 2023
Read more
-
My Pathomation new release at the ECDP
Wednesday June 14th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator